Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Contraception (Levonorgestrel - Contraception)

Records returned : 17 (on 29 May 2025 at 10:51:56). Return to search results for ' Contraception '.

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
1.
Drug:
Indication :
Status :
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Indication :
Status :
Green
Formulations :
  • Intrauterine device (progestogen only)
Restrictions / Comments:

Important

Levosert

 
Links :
Indication :
Status :
Green
Formulations :
  • Intrauterine device (progestogen only)
Restrictions / Comments:

Important

Mirena

May be particularly useful in women with heavy menstrual bleeding requiring (reversible) contraception.

Option for polycystic ovary syndrome.

RSFT: 2nd line for contraception and heavy menstrual bleeding for use when Benilexa is unsuitable of unavailable.

RSFT: Endometrial protection as part of HRT in both peri and postmenopausal women

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important

Norgeston

progesterone only pill, POP

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Intrauterine device (progestogen only)
Restrictions / Comments:

Important

Jaydess 13.5mg

SASH: Jaydess is restriced to those patients who require a smaller size / lower dose of levonorgestrel

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Intrauterine device (progestogen only)
Restrictions / Comments:

Important

Kyleena 19.5mg.

RSFT: Kyleena should only be used in nulliparous patients under 25 years onld and those unable to use the alternative devices.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Intrauterine device (progestogen only)
Restrictions / Comments:

Important

Benilexa One Handed

RSFT: 1st line for contraception and treatment of heavy menstrual bleeding for females between the ages of 18 and 45 years.

Option for polycystic ovary syndrome. May be particularly useful in women wih hevy menstrual bleeding requiring (reversible) contraception.

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Preferred brands: Gedarel 20/150, Bimezza

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Mercilon

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Preferred brands: Millinette 20/75

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Sunya, Akizza 75/20

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Femodette

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Preferred brands = Levest, Rigevidon, Maexeni,

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Microgynon 30 ED, TriRegol, Logynon, Logynon ED

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Ovranette / Ambelina / Microgynon 30 - not for new initiations. Existing patients may remain on current brand.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Elevin brand is not a cost effective option. 

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

2nd line after desogestrel. Caution - may have different drug interactions to other progestogen-only pills.
 
Links :